926 related articles for article (PubMed ID: 32640381)
21. Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel
Sencanski M; Perovic V; Pajovic SB; Adzic M; Paessler S; Glisic S
Molecules; 2020 Aug; 25(17):. PubMed ID: 32842509
[TBL] [Abstract][Full Text] [Related]
22. Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study.
Hosseini FS; Amanlou M
Life Sci; 2020 Oct; 258():118205. PubMed ID: 32777300
[TBL] [Abstract][Full Text] [Related]
23. Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease.
Huynh T; Wang H; Luan B
Phys Chem Chem Phys; 2020 Nov; 22(43):25335-25343. PubMed ID: 33140777
[TBL] [Abstract][Full Text] [Related]
24. Computational insights into tetracyclines as inhibitors against SARS-CoV-2 M
Bharadwaj S; Lee KE; Dwivedi VD; Kang SG
Life Sci; 2020 Sep; 257():118080. PubMed ID: 32653520
[TBL] [Abstract][Full Text] [Related]
25. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
Elfiky AA
Life Sci; 2020 May; 248():117477. PubMed ID: 32119961
[TBL] [Abstract][Full Text] [Related]
26. Analyses of Coronavirus Assembly Interactions with Interspecies Membrane and Nucleocapsid Protein Chimeras.
Kuo L; Hurst-Hess KR; Koetzner CA; Masters PS
J Virol; 2016 May; 90(9):4357-4368. PubMed ID: 26889024
[TBL] [Abstract][Full Text] [Related]
27. Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2.
Sharma K; Morla S; Goyal A; Kumar S
Life Sci; 2020 Oct; 259():118169. PubMed ID: 32738360
[TBL] [Abstract][Full Text] [Related]
28. Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach.
Iftikhar H; Ali HN; Farooq S; Naveed H; Shahzad-Ul-Hussan S
Comput Biol Med; 2020 Jul; 122():103848. PubMed ID: 32658735
[TBL] [Abstract][Full Text] [Related]
29. Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data.
Chakraborti S; Bheemireddy S; Srinivasan N
Mol Omics; 2020 Oct; 16(5):474-491. PubMed ID: 32696772
[TBL] [Abstract][Full Text] [Related]
30. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.
Aftab SO; Ghouri MZ; Masood MU; Haider Z; Khan Z; Ahmad A; Munawar N
J Transl Med; 2020 Jul; 18(1):275. PubMed ID: 32635935
[TBL] [Abstract][Full Text] [Related]
31. Putative SARS-CoV-2 M
Mazzini S; Musso L; Dallavalle S; Artali R
Molecules; 2020 Aug; 25(16):. PubMed ID: 32824454
[TBL] [Abstract][Full Text] [Related]
32. Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods.
Unni S; Aouti S; Thiyagarajan S; Padmanabhan B
J Biosci; 2020; 45(1):. PubMed ID: 33184246
[TBL] [Abstract][Full Text] [Related]
33. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
Khan MI; Khan ZA; Baig MH; Ahmad I; Farouk AE; Song YG; Dong JJ
PLoS One; 2020; 15(9):e0238344. PubMed ID: 32881907
[TBL] [Abstract][Full Text] [Related]
34. Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
Calligari P; Bobone S; Ricci G; Bocedi A
Viruses; 2020 Apr; 12(4):. PubMed ID: 32295237
[TBL] [Abstract][Full Text] [Related]
35. Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA.
Bello M; Martínez-Muñoz A; Balbuena-Rebolledo I
J Mol Model; 2020 Nov; 26(12):340. PubMed ID: 33184722
[TBL] [Abstract][Full Text] [Related]
36. Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay.
Pitsillou E; Liang J; Ververis K; Hung A; Karagiannis TC
J Mol Graph Model; 2021 May; 104():107851. PubMed ID: 33556646
[TBL] [Abstract][Full Text] [Related]
37. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
Vardhan S; Sahoo SK
Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
[TBL] [Abstract][Full Text] [Related]
38. An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors.
Trezza A; Iovinelli D; Santucci A; Prischi F; Spiga O
Sci Rep; 2020 Aug; 10(1):13866. PubMed ID: 32807895
[TBL] [Abstract][Full Text] [Related]
39.
Sachdeva C; Wadhwa A; Kumari A; Hussain F; Jha P; Kaushik NK
OMICS; 2020 Oct; 24(10):568-580. PubMed ID: 32757981
[TBL] [Abstract][Full Text] [Related]
40. Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (M
Rao P; Shukla A; Parmar P; Rawal RM; Patel B; Saraf M; Goswami D
Biophys Chem; 2020 Sep; 264():106425. PubMed ID: 32663708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
